Related Experiment Video

Updated: Feb 27, 2026

Neuroimaging Field Methods Using Functional Near Infrared Spectroscopy NIRS Neuroimaging to Study Global Child Development: Rural Sub-Saharan Africa
08:10

Neuroimaging Field Methods Using Functional Near Infrared Spectroscopy NIRS Neuroimaging to Study Global Child Development: Rural Sub-Saharan Africa

Published on: February 2, 2018

15.7K

The Swiss regulatory framework for paediatric health research

Valerie Junod1

  • 1University of Geneva Law School.

European Journal of Health Law
|November 8, 2008
PubMed

Insights

Swiss law permits medical research on children, including drug trials, provided ethics committees ensure a favorable risk-benefit balance. Ongoing revisions aim to broaden protections and incentivize pediatric drug development.

Area of Science:

  • Medical research ethics
  • Pediatric drug development
  • Swiss healthcare law

Background:

  • Medical research involving minors presents unique ethical considerations.
  • Swiss law permits clinical trials on children, including non-therapeutic drug trials.
  • Existing regulations require ethics committee verification of favorable risk-benefit profiles for all studies.

Purpose of the Study:

  • To analyze the legal and ethical framework for medical research on minors in Switzerland.
  • To examine current and proposed safeguards for children participating in health research.
  • To understand initiatives aimed at improving pediatric drug development and labeling.

Main Methods:

  • Review of Swiss federal law pertaining to clinical trials and health research involving minors.
  • Analysis of regulatory requirements for ethics committee oversight.
  • Examination of policies related to pharmaceutical incentives for pediatric drug development.

Main Results:

  • Swiss law permits clinical trials on children under strict ethical oversight.
  • Additional safeguards are in place to protect children from unnecessary research involvement and ensure informed consent.
  • Federal law is being revised to extend protections to broader health research, and the Swiss drug agency is working to improve incentives for pediatric drug development.

Conclusions:

  • Swiss regulatory frameworks prioritize child protection in medical research while permitting necessary studies.
  • Ongoing legal revisions and agency initiatives aim to strengthen protections and encourage the development of pediatric medicines.
  • The systematic verification of risk-benefit profiles by ethics committees is crucial for ethical research on minors.

More Related Videos

Working with Human Tissues for Translational Cancer Research07:48

Working with Human Tissues for Translational Cancer Research

Published on: November 26, 2015

10.4K
Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure15:18

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

Published on: July 30, 2009

18.7K

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
190
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
381
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
334
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.1K
Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
25.9K